{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:34:28Z","timestamp":1790818468560,"version":"4.1.0"},"reference-count":228,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Dis Primers"],"DOI":"10.1038\/s41572-026-00735-5","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:02:02Z","timestamp":1788418922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Varicella zoster virus infection"],"prefix":"10.1038","volume":"12","author":[{"given":"Andrew N.","family":"Bubak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Warren-Gash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4314-5088","authenticated-orcid":false,"given":"Cristina","family":"Tommasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8246-0534","authenticated-orcid":false,"given":"Judith","family":"Breuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Mahalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padma","family":"Srikanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"735_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03569-2","volume":"9","author":"DP Depledge","year":"2018","unstructured":"Depledge, D. P. et al. A spliced latency-associated VZV transcript maps antisense to the viral transactivator gene 61. Nat. Commun. 9, 1167 (2018).","journal-title":"Nat. Commun."},{"key":"735_CR2","first-page":"17","volume":"123","author":"AA Gershon","year":"2012","unstructured":"Gershon, A. A. et al. Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children. Trans. Am. Clin. Climatol. Assoc. 123, 17\u201333 (2012).","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"735_CR3","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.1073\/pnas.95.8.4658","volume":"95","author":"PG Kennedy","year":"1998","unstructured":"Kennedy, P. G., Grinfeld, E. & Gow, J. W. Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc. Natl Acad. Sci. USA 95, 4658\u20134662 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"735_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1056\/NEJM199009063231002","volume":"323","author":"R Mahalingam","year":"1990","unstructured":"Mahalingam, R. et al. Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia. N. Engl. J. Med. 323, 627\u2013631 (1990).","journal-title":"N. Engl. J. Med."},{"key":"735_CR5","doi-asserted-by":"publisher","first-page":"8189","DOI":"10.1128\/JVI.01070-14","volume":"88","author":"MA Nagel","year":"2014","unstructured":"Nagel, M. A. et al. Frequency and abundance of alphaherpesvirus DNA in human thoracic sympathetic ganglia. J. Virol. 88, 8189\u20138192 (2014).","journal-title":"J. Virol."},{"key":"735_CR6","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1086\/648474","volume":"200","author":"ER Richter","year":"2009","unstructured":"Richter, E. R., Dias, J. K., Gilbert, J. E. II & Atherton, S. S. Distribution of herpes simplex virus type 1 and varicella zoster virus in ganglia of the human head and neck. J. Infect. Dis. 200, 1901\u20131906 (2009).","journal-title":"J. Infect. Dis."},{"key":"735_CR7","doi-asserted-by":"publisher","first-page":"10203","DOI":"10.1128\/JVI.01331-12","volume":"86","author":"WJ Ouwendijk","year":"2012","unstructured":"Ouwendijk, W. J. et al. Restricted varicella-zoster virus transcription in human trigeminal ganglia obtained soon after death. J. Virol. 86, 10203\u201310206 (2012).","journal-title":"J. Virol."},{"key":"735_CR8","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1093\/infdis\/jiy425","volume":"218","author":"MA Nagel","year":"2018","unstructured":"Nagel, M. A. & Bubak, A. N. Varicella zoster virus vasculopathy. J. Infect. Dis. 218, S107\u2013S112 (2018).","journal-title":"J. Infect. Dis."},{"key":"735_CR9","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.mayocp.2019.03.020","volume":"94","author":"MA Nagel","year":"2019","unstructured":"Nagel, M. A. & Bubak, A. N. Herpes zoster, a rash of cerebrovascular events. Mayo Clin. Proc. 94, 742\u2013744 (2019).","journal-title":"Mayo Clin. Proc."},{"key":"735_CR10","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1212\/01.wnl.0000304747.38502.e8","volume":"70","author":"MA Nagel","year":"2008","unstructured":"Nagel, M. A. et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology 70, 853\u2013860 (2008).","journal-title":"Neurology"},{"key":"735_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1212\/WNL.0b013e3182267bfa","volume":"77","author":"MA Nagel","year":"2011","unstructured":"Nagel, M. A. et al. Varicella zoster virus vasculopathy: analysis of virus-infected arteries. Neurology 77, 364\u2013370 (2011).","journal-title":"Neurology"},{"key":"735_CR12","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3949\/ccjm.74.7.489","volume":"74","author":"MA Nagel","year":"2007","unstructured":"Nagel, M. A. & Gilden, D. H. The protean neurologic manifestations of varicella-zoster virus infection. Clevel. Clin. J. Med. 74, 489\u2013494 (2007).","journal-title":"Clevel. Clin. J. Med."},{"key":"735_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/jnnp.71.2.149","volume":"71","author":"C Sweeney","year":"2001","unstructured":"Sweeney, C. & Gilden, D. Ramsay hunt syndrome. J. Neurol. Neurosurg. Psychiatry 71, 149\u2013154 (2001).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"735_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens15020157","author":"W Gu","year":"2026","unstructured":"Gu, W. et al. Varicella-zoster virus and the eye: clinical spectrum, management, and vaccination. Pathogens 15, 157 https:\/\/doi.org\/10.3390\/pathogens15020157 (2026).","journal-title":"Pathogens"},{"key":"735_CR15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/ICO.0000000000001046","volume":"36","author":"SK Szeto","year":"2017","unstructured":"Szeto, S. K. et al. Prevalence of ocular manifestations and visual outcomes in patients with herpes zoster ophthalmicus. Cornea 36, 338\u2013342 (2017).","journal-title":"Cornea"},{"key":"735_CR16","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/ICU.0000000000000996","volume":"34","author":"TO Tofade","year":"2023","unstructured":"Tofade, T. O. & Chwalisz, B. K. Neuro-ophthalmic complications of varicella-zoster virus. Curr. Opin. Ophthalmol. 34, 470\u2013475 (2023).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"735_CR17","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.mayocp.2013.03.014","volume":"88","author":"BP Yawn","year":"2013","unstructured":"Yawn, B. P., Wollan, P. C., St Sauver, J. L. & Butterfield, L. C. Herpes zoster eye complications: rates and trends. Mayo Clin. Proc. 88, 562\u2013570 (2013).","journal-title":"Mayo Clin. Proc."},{"key":"735_CR18","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1212\/WNL.44.10.1818","volume":"44","author":"DH Gilden","year":"1994","unstructured":"Gilden, D. H. et al. Varicella-zoster virus myelitis: an expanding spectrum. Neurology 44, 1818\u20131823 (1994).","journal-title":"Neurology"},{"key":"735_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.027451","volume":"11","author":"SG Curhan","year":"2022","unstructured":"Curhan, S. G. et al. Herpes zoster and long-term risk of cardiovascular disease. J. Am. Heart Assoc. 11, e027451 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"735_CR20","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s13365-011-0070-1","volume":"17","author":"JJ Chen","year":"2011","unstructured":"Chen, J. J., Gershon, A. A., Li, Z., Cowles, R. A. & Gershon, M. D. Varicella zoster virus (VZV) infects and establishes latency in enteric neurons. J. Neurovirol 17, 578\u2013589 (2011).","journal-title":"J. Neurovirol"},{"key":"735_CR21","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.1093\/infdis\/jiy407","volume":"218","author":"M Gershon","year":"2018","unstructured":"Gershon, M. & Gershon, A. Varicella-zoster virus and the enteric nervous system. J. Infect. Dis. 218, S113\u2013S119 (2018).","journal-title":"J. Infect. Dis."},{"key":"735_CR22","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.amepre.2024.06.018","volume":"67","author":"MF Helm","year":"2024","unstructured":"Helm, M. F. et al. Zoster vaccine lowers stroke and myocardial infarction risk in chronic disease. Am. J. Prev. Med. 67, 676\u2013683 (2024).","journal-title":"Am. J. Prev. Med."},{"key":"735_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/v17121591","author":"A Livieratos","year":"2025","unstructured":"Livieratos, A., Schiro, L. E., Gogos, C., Ntaios, G. & Akinosoglou, K. Varicella zoster virus and stroke: an intricate relationship. Viruses 17, 1591\u00a0https:\/\/doi.org\/10.3390\/v17121591 (2025).","journal-title":"Viruses"},{"key":"735_CR24","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s13365-023-01144-0","volume":"29","author":"P Lu","year":"2023","unstructured":"Lu, P., Cui, L. & Zhang, X. Stroke risk after varicella-zoster virus infection: a systematic review and meta-analysis. J. Neurovirol 29, 449\u2013459 (2023).","journal-title":"J. Neurovirol"},{"key":"735_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41579-026-01289-9","volume":"24","author":"B Ogunjimi","year":"2026","unstructured":"Ogunjimi, B. et al. Varicella zoster virus and the central nervous system. Nat. Rev. Microbiol. 24, 425\u2013439 (2026).","journal-title":"Nat. Rev. Microbiol."},{"key":"735_CR26","doi-asserted-by":"publisher","first-page":"ofac118","DOI":"10.1093\/ofid\/ofac118","volume":"9","author":"A Bhavsar","year":"2022","unstructured":"Bhavsar, A. et al. Increased risk of herpes zoster in adults \u226550 years old diagnosed with COVID-19 in the United States. Open Forum Infect. Dis. 9, ofac118 (2022).","journal-title":"Open Forum Infect. Dis."},{"key":"735_CR27","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1046\/j.1365-3156.1998.00316.x","volume":"3","author":"BW Lee","year":"1998","unstructured":"Lee, B. W. Review of varicella zoster seroepidemiology in India and Southeast Asia. Trop. Med. Int. Health 3, 886\u2013890 (1998).","journal-title":"Trop. Med. Int. Health"},{"key":"735_CR28","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1002\/jmv.27538","volume":"94","author":"J Huang","year":"2022","unstructured":"Huang, J. et al. The global disease burden of varicella-zoster virus infection from 1990 to 2019. J. Med. Virol. 94, 2736\u20132746 (2022).","journal-title":"J. Med. Virol."},{"key":"735_CR29","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1017\/S0950268817001546","volume":"145","author":"K Bollaerts","year":"2017","unstructured":"Bollaerts, K. et al. A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data. Epidemiol. Infect. 145, 2666\u20132677 (2017).","journal-title":"Epidemiol. Infect."},{"key":"735_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1542\/peds.2013-4251","volume":"134","author":"R Baxter","year":"2014","unstructured":"Baxter, R. et al. Impact of vaccination on the epidemiology of varicella: 1995\u20132009. Pediatrics 134, 24\u201330 (2014).","journal-title":"Pediatrics"},{"key":"735_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-6795-0","volume":"19","author":"LHF Arlant","year":"2019","unstructured":"Arlant, L. H. F. et al. Burden of varicella in Latin America and the Caribbean: findings from a systematic literature review. BMC Public Health 19, 528 (2019).","journal-title":"BMC Public Health"},{"key":"735_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/jrms.JRMS_979_17","volume":"23","author":"M Al-Turab","year":"2018","unstructured":"Al-Turab, M. & Chehadeh, W. Varicella infection in the Middle East: prevalence, complications, and vaccination. J. Res. Med. Sci. 23, 19 (2018).","journal-title":"J. Res. Med. Sci."},{"key":"735_CR33","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1080\/14760584.2019.1594781","volume":"18","author":"AEN Goh","year":"2019","unstructured":"Goh, A. E. N. et al. Burden of varicella in the Asia-Pacific region: a systematic literature review. Expert Rev. Vaccines 18, 475\u2013493 (2019).","journal-title":"Expert Rev. Vaccines"},{"key":"735_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4103\/1995-7645.223561","volume":"11","author":"HM Munasingha","year":"2018","unstructured":"Munasingha, H. M., Amarasinghe, A., Malavige, N. G. & Sathiakumar, N. Seroprevalence of varicella zoster virus in Colombo district, Sri Lanka. Asian Pac. J. Tropic. Med. 11, 53\u201357 (2018).","journal-title":"Asian Pac. J. Tropic. Med."},{"key":"735_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijid.2013.10.003","volume":"22","author":"N Fatha","year":"2014","unstructured":"Fatha, N., Ang, L. W. & Goh, K. T. Changing seroprevalence of varicella zoster virus infection in a tropical city state, Singapore. Int. J. Infect. Dis. 22, 73\u201377 (2014).","journal-title":"Int. J. Infect. Dis."},{"key":"735_CR36","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268822001923","volume":"151","author":"O Adam","year":"2022","unstructured":"Adam, O., Musa, A., Kamer, A., Benharrat, S. & Hubschen, J. M. Active circulation of varicella zoster virus among different age groups in Sudan. Epidemiol. Infect. 151, e10 (2022).","journal-title":"Epidemiol. Infect."},{"key":"735_CR37","doi-asserted-by":"publisher","first-page":"6689","DOI":"10.1073\/pnas.1523941113","volume":"113","author":"KM Bakker","year":"2016","unstructured":"Bakker, K. M., Martinez-Bakker, M. E., Helm, B. & Stevenson, T. J. Digital epidemiology reveals global childhood disease seasonality and the effects of immunization. Proc. Natl Acad. Sci. USA 113, 6689\u20136694 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"735_CR38","doi-asserted-by":"publisher","DOI":"10.2196\/62863","volume":"10","author":"K Zhang","year":"2024","unstructured":"Zhang, K., Shen, G., Yuan, Y. & Shi, C. Association between climatic factors and varicella incidence in Wuxi, East China, 2010\u20132019: surveillance study. J. Med. Internet Res. Public Health Surveill. 10, e62863 (2024).","journal-title":"J. Med. Internet Res. Public Health Surveill."},{"key":"735_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s40121-023-00899-7","volume":"13","author":"HA Shah","year":"2024","unstructured":"Shah, H. A. et al. Global prevalence of varicella-associated complications: a systematic review and meta-analysis. Infect. Dis. Ther. 13, 79\u2013103 (2024).","journal-title":"Infect. Dis. Ther."},{"key":"735_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26041132","author":"G Andrei","year":"2021","unstructured":"Andrei, G. & Snoeck, R. Advances and perspectives in the management of varicella-zoster virus infections. Molecules 26, 1132 https:\/\/doi.org\/10.3390\/molecules26041132 (2021).","journal-title":"Molecules"},{"key":"735_CR41","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.jpeds.2014.06.014","volume":"165","author":"M Science","year":"2014","unstructured":"Science, M. et al. Central nervous system complications of varicella-zoster virus. J. Pediatr. 165, 779\u2013785 (2014).","journal-title":"J. Pediatr."},{"key":"735_CR42","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1161\/01.STR.32.6.1257","volume":"32","author":"R Askalan","year":"2001","unstructured":"Askalan, R. et al. Chickenpox and stroke in childhood: a study of frequency and causation. Stroke 32, 1257\u20131262 (2001).","journal-title":"Stroke"},{"key":"735_CR43","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1080\/21645515.2020.1847582","volume":"17","author":"D van Oorschot","year":"2021","unstructured":"van Oorschot, D. et al. A systematic literature review of herpes zoster incidence worldwide. Hum. Vaccin. Immunother. 17, 1714\u20131732 (2021).","journal-title":"Hum. Vaccin. Immunother."},{"key":"735_CR44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/cid\/ciw296","volume":"63","author":"K Kawai","year":"2016","unstructured":"Kawai, K., Yawn, B. P., Wollan, P. & Harpaz, R. Increasing incidence of herpes zoster over a 60-year period from a population-based study. Clin. Infect. Dis. 63, 221\u2013226 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"735_CR45","first-page":"9","volume":"58","author":"RE Hope-Simpson","year":"1965","unstructured":"Hope-Simpson, R. E. The nature of herpes zoster: a long-term study and a new hypothesis. Proc. R. Soc. Med. 58, 9\u201320 (1965).","journal-title":"Proc. R. Soc. Med."},{"key":"735_CR46","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1093\/cid\/ciz1090","volume":"71","author":"SL McKay","year":"2020","unstructured":"McKay, S. L., Guo, A., Pergam, S. A. & Dooling, K. Herpes zoster risk in immunocompromised adults in the United States: a systematic review. Clin. Infect. Dis. 71, e125\u2013e134 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"735_CR47","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s40121-024-00963-w","volume":"13","author":"A Marijam","year":"2024","unstructured":"Marijam, A. et al. Systematic literature review on the incidence of herpes zoster in populations at increased risk of disease in the EU\/EEA, Switzerland, and the UK. Infect. Dis. Ther. 13, 1083\u20131104 (2024).","journal-title":"Infect. Dis. Ther."},{"key":"735_CR48","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1007\/s10096-021-04298-z","volume":"40","author":"E Rafferty","year":"2021","unstructured":"Rafferty, E. et al. The impact of varicella vaccination on paediatric herpes zoster epidemiology: a Canadian population-based retrospective cohort study. Eur. J. Clin. Microbiol. Infect. Dis. 40, 2363\u20132370 (2021).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"735_CR49","doi-asserted-by":"publisher","first-page":"8580","DOI":"10.1016\/j.vaccine.2011.09.024","volume":"29","author":"P Tanuseputro","year":"2011","unstructured":"Tanuseputro, P., Zagorski, B., Chan, K. J. & Kwong, J. C. Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program. Vaccine 29, 8580\u20138584 (2011).","journal-title":"Vaccine"},{"key":"735_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07479-z","volume":"22","author":"SL Cadogan","year":"2022","unstructured":"Cadogan, S. L., Mindell, J. S., Breuer, J., Hayward, A. & Warren-Gash, C. Prevalence of and factors associated with herpes zoster in England: a cross-sectional analysis of the Health Survey for England. BMC Infect. Dis. 22, 513 (2022).","journal-title":"BMC Infect. Dis."},{"key":"735_CR51","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa005","volume":"7","author":"F Marra","year":"2020","unstructured":"Marra, F., Parhar, K., Huang, B. & Vadlamudi, N. Risk factors for herpes zoster infection: a meta-analysis. Open Forum Infect. Dis. 7, ofaa005 (2020).","journal-title":"Open Forum Infect. Dis."},{"key":"735_CR52","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1093\/infdis\/jis937","volume":"207","author":"JX Zhang","year":"2013","unstructured":"Zhang, J. X., Joesoef, R. M., Bialek, S., Wang, C. & Harpaz, R. Association of physical trauma with risk of herpes zoster among Medicare beneficiaries in the United States. J. Infect. Dis. 207, 1007\u20131011 (2013).","journal-title":"J. Infect. Dis."},{"key":"735_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29629","volume":"96","author":"F Wang","year":"2024","unstructured":"Wang, F., Gao, Y., Wagner, A. L. & Lu, Y. A systematic review and meta-analysis of herpes zoster occurrence\/recurrence after COVID-19 infection and vaccination. J. Med. Virol. 96, e29629 (2024).","journal-title":"J. Med. Virol."},{"key":"735_CR54","doi-asserted-by":"publisher","first-page":"E245","DOI":"10.1111\/1469-0691.12131","volume":"19","author":"V Papaevangelou","year":"2013","unstructured":"Papaevangelou, V. et al. Subclinical VZV reactivation in immunocompetent children hospitalized in the ICU associated with prolonged fever duration. Clin. Microbiol. Infect. 19, E245\u2013E251 (2013).","journal-title":"Clin. Microbiol. Infect."},{"key":"735_CR55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fmicb.2019.00016","volume":"10","author":"BV Rooney","year":"2019","unstructured":"Rooney, B. V., Crucian, B. E., Pierson, D. L., Laudenslager, M. L. & Mehta, S. K. Herpes virus reactivation in astronauts during spaceflight and its application on Earth. Front. Microbiol. 10, 16 (2019).","journal-title":"Front. Microbiol."},{"key":"735_CR56","doi-asserted-by":"publisher","DOI":"10.1128\/mmbr.00116-22","volume":"87","author":"AM Arvin","year":"2023","unstructured":"Arvin, A. M. Creating the \u201cdew drop on a rose petal\u201d: the molecular pathogenesis of varicella-zoster virus skin lesions. Microbiol. Mol. Biol. Rev. 87, e0011622 (2023).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"735_CR57","doi-asserted-by":"publisher","first-page":"982","DOI":"10.3390\/v14050982","volume":"14","author":"C Tommasi","year":"2022","unstructured":"Tommasi, C. & Breuer, J. The biology of varicella-zoster virus replication in the skin. Viruses 14, 982\u00a0https:\/\/doi.org\/10.3390\/v14050982 (2022).","journal-title":"Viruses"},{"key":"735_CR58","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1128\/JVI.75.13.6183-6192.2001","volume":"75","author":"A Abendroth","year":"2001","unstructured":"Abendroth, A., Morrow, G., Cunningham, A. L. & Slobedman, B. Varicella-zoster virus infection of human dendritic cells and transmission to T cells: implications for virus dissemination in the host. J. Virol. 75, 6183\u20136192 (2001).","journal-title":"J. Virol."},{"key":"735_CR59","doi-asserted-by":"publisher","first-page":"4950","DOI":"10.1128\/JVI.77.8.4950-4959.2003","volume":"77","author":"G Morrow","year":"2003","unstructured":"Morrow, G., Slobedman, B., Cunningham, A. L. & Abendroth, A. Varicella-zoster virus productively infects mature dendritic cells and alters their immune function. J. Virol. 77, 4950\u20134959 (2003).","journal-title":"J. Virol."},{"key":"735_CR60","doi-asserted-by":"publisher","first-page":"11425","DOI":"10.1128\/JVI.76.22.11425-11433.2002","volume":"76","author":"CC Ku","year":"2002","unstructured":"Ku, C. C., Padilla, J. A., Grose, C., Butcher, E. C. & Arvin, A. M. Tropism of varicella-zoster virus for human tonsillar CD4+ T lymphocytes that express activation, memory, and skin homing markers. J. Virol. 76, 11425\u201311433 (2002).","journal-title":"J. Virol."},{"key":"735_CR61","doi-asserted-by":"publisher","first-page":"5236","DOI":"10.1128\/jvi.69.9.5236-5242.1995","volume":"69","author":"JF Moffat","year":"1995","unstructured":"Moffat, J. F., Stein, M. D., Kaneshima, H. & Arvin, A. M. Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice. J. Virol. 69, 5236\u20135242 (1995).","journal-title":"J. Virol."},{"key":"735_CR62","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.celrep.2014.06.024","volume":"8","author":"N Sen","year":"2014","unstructured":"Sen, N. et al. Single-cell mass cytometry analysis of human tonsil T cell remodeling by varicella zoster virus. Cell Rep. 8, 633\u2013645 (2014).","journal-title":"Cell Rep."},{"key":"735_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006999","volume":"14","author":"TM Campbell","year":"2018","unstructured":"Campbell, T. M. et al. Varicella zoster virus productively infects human natural killer cells and manipulates phenotype. PLoS Pathog. 14, e1006999 (2018).","journal-title":"PLoS Pathog."},{"key":"735_CR64","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrmicro3215","volume":"12","author":"L Zerboni","year":"2014","unstructured":"Zerboni, L., Sen, N., Oliver, S. L. & Arvin, A. M. Molecular mechanisms of varicella zoster virus pathogenesis. Nat. Rev. Microbiol. 12, 197\u2013210 (2014).","journal-title":"Nat. Rev. Microbiol."},{"key":"735_CR65","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-7091-6259-0_12","author":"T Iwasaki","year":"2001","unstructured":"Iwasaki, T. et al. Pathway of viral spread in herpes zoster: detection of the protein encoded by open reading frame 63 of varicella-zoster virus in biopsy specimens. In Immunity to and Prevention of Herpes Zoster (eds Gershon, A. A. et al.) 109\u2013119\u00a0https:\/\/doi.org\/10.1007\/978-3-7091-6259-0_12 (Springer, 2001).","journal-title":"Immunity to and Prevention of Herpes Zoster"},{"key":"735_CR66","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/BF00196701","volume":"428","author":"R Muraki","year":"1996","unstructured":"Muraki, R., Iwasaki, T., Sata, T., Sato, Y. & Kurata, T. Hair follicle involvement in herpes zoster: pathway of viral spread from ganglia to skin. Virchows Arch. 428, 275\u2013280 (1996).","journal-title":"Virchows Arch."},{"key":"735_CR67","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1084\/jem.20040634","volume":"200","author":"CC Ku","year":"2004","unstructured":"Ku, C. C. et al. Varicella-zoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-\u03b1. J. Exp. Med. 200, 917\u2013925 (2004).","journal-title":"J. Exp. Med."},{"key":"735_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003896","volume":"10","author":"M Jones","year":"2014","unstructured":"Jones, M. et al. RNA-seq analysis of host and viral gene expression highlights interaction between varicella zoster virus and keratinocyte differentiation. PLoS Pathog. 10, e1003896 (2014).","journal-title":"PLoS Pathog."},{"key":"735_CR69","first-page":"173","volume":"342","author":"MD Gershon","year":"2010","unstructured":"Gershon, M. D. & Gershon, A. A. VZV infection of keratinocytes: production of cell-free infectious virions in vivo. Curr. Top. Microbiol. Immunol. 342, 173\u2013188 (2010).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"735_CR70","doi-asserted-by":"publisher","unstructured":"Tommasi, C. et al. Comparative analysis of varicella-zoster virus and herpes simplex virus 1 interaction with epidermal terminal differentiation in primary human keratinocytes models of differentiation. Preprint at bioRxiv https:\/\/doi.org\/10.64898\/2026.04.08.717198 (2026).","DOI":"10.64898\/2026.04.08.717198"},{"key":"735_CR71","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jid.2019.08.448","volume":"140","author":"C Tommasi","year":"2020","unstructured":"Tommasi, C. et al. Kallikrein-mediated cytokeratin 10 degradation is required for varicella zoster virus propagation in skin. J. Investig. Dermatol. 140, 774\u2013784.e711 (2020).","journal-title":"J. Investig. Dermatol."},{"key":"735_CR72","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12985-024-02514-8","volume":"21","author":"C Tommasi","year":"2024","unstructured":"Tommasi, C. et al. Upregulation of keratin 15 is required for varicella-zoster virus replication in keratinocytes and is attenuated in the live attenuated vOka vaccine strain. Virol. J. 21, 253 (2024).","journal-title":"Virol. J."},{"key":"735_CR73","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/infdis\/154.3.422","volume":"154","author":"AM Arvin","year":"1986","unstructured":"Arvin, A. M., Koropchak, C. M., Williams, B. R., Grumet, F. C. & Foung, S. K. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J. Infect. Dis. 154, 422\u2013429 (1986).","journal-title":"J. Infect. Dis."},{"key":"735_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002367","volume":"7","author":"K Haberthur","year":"2011","unstructured":"Haberthur, K. et al. CD4 T cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of VZV infection. PLoS Pathog. 7, e1002367 (2011).","journal-title":"PLoS Pathog."},{"key":"735_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000657","volume":"5","author":"I Messaoudi","year":"2009","unstructured":"Messaoudi, I. et al. Simian varicella virus infection of rhesus macaques recapitulates essential features of varicella zoster virus infection in humans. PLoS Pathog. 5, e1000657 (2009).","journal-title":"PLoS Pathog."},{"key":"735_CR76","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3109\/08820138809055722","volume":"17","author":"AD Webster","year":"1988","unstructured":"Webster, A. D., Spickett, G. P., Thomson, B. J. & Farrant, J. Viruses and antibody deficiency syndromes. Immunol. Investig. 17, 93\u2013105 (1988).","journal-title":"Immunol. Investig."},{"key":"735_CR77","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s13365-016-0425-8","volume":"22","author":"H Badani","year":"2016","unstructured":"Badani, H. et al. Frequency of varicella zoster virus DNA in human adrenal glands. J. Neurovirol 22, 400\u2013402 (2016).","journal-title":"J. Neurovirol"},{"key":"735_CR78","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.1128\/JVI.77.12.6979-6987.2003","volume":"77","author":"MJ Levin","year":"2003","unstructured":"Levin, M. J., Cai, G. Y., Manchak, M. D. & Pizer, L. I. Varicella-zoster virus DNA in cells isolated from human trigeminal ganglia. J. Virol. 77, 6979\u20136987 (2003).","journal-title":"J. Virol."},{"key":"735_CR79","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.3389\/fmicb.2018.03170","volume":"9","author":"O Sorel","year":"2018","unstructured":"Sorel, O. & Messaoudi, I. Varicella virus\u2013host interactions during latency and reactivation: lessons from simian varicella virus. Front. Microbiol. 9, 3170 (2018).","journal-title":"Front. Microbiol."},{"key":"735_CR80","doi-asserted-by":"publisher","first-page":"14079","DOI":"10.1128\/JVI.79.22.14079-14087.2005","volume":"79","author":"K Wang","year":"2005","unstructured":"Wang, K., Lau, T. Y., Morales, M., Mont, E. K. & Straus, S. E. Laser-capture microdissection: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal ganglia at the single-cell level. J. Virol. 79, 14079\u201314087 (2005).","journal-title":"J. Virol."},{"key":"735_CR81","doi-asserted-by":"publisher","first-page":"8151","DOI":"10.1128\/jvi.69.12.8151-8154.1995","volume":"69","author":"P Clarke","year":"1995","unstructured":"Clarke, P., Beer, T., Cohrs, R. & Gilden, D. H. Configuration of latent varicella-zoster virus DNA. J. Virol. 69, 8151\u20138154 (1995).","journal-title":"J. Virol."},{"key":"735_CR82","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.3390\/v13112289","volume":"13","author":"SE Braspenning","year":"2021","unstructured":"Braspenning, S. E. et al. Mutagenesis of the varicella-zoster virus genome demonstrates that VLT and VLT\u2013ORF63 proteins are dispensable for lytic infection. Viruses 13, 2289 https:\/\/doi.org\/10.3390\/v13112289 (2021).","journal-title":"Viruses"},{"key":"735_CR83","doi-asserted-by":"publisher","first-page":"8294","DOI":"10.1128\/JVI.01112-13","volume":"87","author":"C Meyer","year":"2013","unstructured":"Meyer, C. et al. Age and immune status of rhesus macaques impact simian varicella virus gene expression in sensory ganglia. J. Virol. 87, 8294\u20138306 (2013).","journal-title":"J. Virol."},{"key":"735_CR84","doi-asserted-by":"publisher","first-page":"e2705","DOI":"10.1093\/cid\/ciaa1274","volume":"73","author":"R Ansari","year":"2021","unstructured":"Ansari, R. et al. Primary and acquired immunodeficiencies associated with severe varicella-zoster virus infections. Clin. Infect. Dis. 73, e2705\u2013e2712 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"735_CR85","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.coi.2020.01.004","volume":"62","author":"E Jouanguy","year":"2020","unstructured":"Jouanguy, E. et al. Human inborn errors of immunity to herpes viruses. Curr. Opin. Immunol. 62, 106\u2013122 (2020).","journal-title":"Curr. Opin. Immunol."},{"key":"735_CR86","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.jaci.2013.11.031","volume":"133","author":"A Sabry","year":"2014","unstructured":"Sabry, A. et al. Vaccine strain varicella-zoster virus-induced central nervous system vasculopathy as the presenting feature of DOCK8 deficiency. J. Allergy Clin. Immunol. 133, 1225\u20131227 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"735_CR87","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.2147\/CCID.S429308","volume":"16","author":"L Zeng","year":"2023","unstructured":"Zeng, L., Feng, S., Yao, L., Zhao, J. & Zhang, G. Disseminated herpes zoster with decreased CD4 counts in a HIV-infected patient. Clin. Cosmet. Investig. Dermatol. 16, 3165\u20133170 (2023).","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"735_CR88","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1365-4632.2004.01649.x","volume":"43","author":"V Wiwanitkit","year":"2004","unstructured":"Wiwanitkit, V. Prevalence of dermatological disorders in Thai HIV-infected patients correlated with different CD4 lymphocyte count statuses: a note on 120 cases. Int. J. Dermatol. 43, 265\u2013268 (2004).","journal-title":"Int. J. Dermatol."},{"key":"735_CR89","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/ijd.14725","volume":"59","author":"YY Li","year":"2020","unstructured":"Li, Y. Y. et al. Effects of CD4 cell count and antiretroviral therapy on mucocutaneous manifestations among HIV\/AIDS patients in Yunnan, China. Int. J. Dermatol. 59, 308\u2013313 (2020).","journal-title":"Int. J. Dermatol."},{"key":"735_CR90","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s13365-017-0522-3","volume":"23","author":"N Arnold","year":"2017","unstructured":"Arnold, N., Meyer, C., Engelmann, F. & Messaoudi, I. Robust gene expression changes in the ganglia following subclinical reactivation in rhesus macaques infected with simian varicella virus. J. Neurovirol 23, 520\u2013538 (2017).","journal-title":"J. Neurovirol"},{"key":"735_CR91","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01375-18","author":"V Traina-Dorge","year":"2019","unstructured":"Traina-Dorge, V. et al. Reactivation of simian varicella virus in rhesus macaques after CD4 T cell depletion. J. Virol. 93, 01375-18 https:\/\/doi.org\/10.1128\/JVI.01375-18 (2019).","journal-title":"J. Virol."},{"key":"735_CR92","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jpeds.2004.11.022","volume":"146","author":"A Etzioni","year":"2005","unstructured":"Etzioni, A. et al. Fatal varicella associated with selective natural killer cell deficiency. J. Pediatr. 146, 423\u2013425 (2005).","journal-title":"J. Pediatr."},{"key":"735_CR93","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jpeds.2005.06.028","volume":"148","author":"LD Notarangelo","year":"2006","unstructured":"Notarangelo, L. D. & Mazzolari, E. Natural killer cell deficiencies and severe varicella infection. J. Pediatr. 148, 563\u2013564 (2006).","journal-title":"J. Pediatr."},{"key":"735_CR94","doi-asserted-by":"publisher","first-page":"omac134","DOI":"10.1093\/omcr\/omac134","volume":"12","author":"H-H Chang","year":"2022","unstructured":"Chang, H.-H., Chen, H. & Lin, W.-H. Herpes zoster infection after rituximab induction therapy in patient with myeloperoxidase\u2013antineutrophil cytoplasmic antibody-associated vasculitis: a case report. Oxf. Med. Case Rep. 12, omac134 (2022).","journal-title":"Oxf. Med. Case Rep."},{"key":"735_CR95","doi-asserted-by":"publisher","first-page":"7844","DOI":"10.1128\/JVI.00325-07","volume":"81","author":"AP Ambagala","year":"2007","unstructured":"Ambagala, A. P. & Cohen, J. I. Varicella-zoster virus IE63, a major viral latency protein, is required to inhibit the \u03b1 interferon-induced antiviral response. J. Virol. 81, 7844\u20137851 (2007).","journal-title":"J. Virol."},{"key":"735_CR96","doi-asserted-by":"publisher","first-page":"11634","DOI":"10.1128\/JVI.01945-14","volume":"88","author":"MA Nagel","year":"2014","unstructured":"Nagel, M. A. et al. Inhibition of phosphorylated-STAT1 nuclear translocation and antiviral protein expression in human brain vascular adventitial fibroblasts infected with varicella-zoster virus. J. Virol. 88, 11634\u201311637 (2014).","journal-title":"J. Virol."},{"key":"735_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004901","volume":"11","author":"MC Verweij","year":"2015","unstructured":"Verweij, M. C. et al. Varicella viruses inhibit interferon-stimulated JAK\u2013STAT signaling through multiple mechanisms. PLoS Pathog. 11, e1004901 (2015).","journal-title":"PLoS Pathog."},{"key":"735_CR98","doi-asserted-by":"publisher","first-page":"9240","DOI":"10.1128\/JVI.01147-10","volume":"84","author":"N Sen","year":"2010","unstructured":"Sen, N. et al. Varicella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: a novel mechanism of IRF3 inhibition among herpesviruses. J. Virol. 84, 9240\u20139253 (2010).","journal-title":"J. Virol."},{"key":"735_CR99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016870","volume":"6","author":"P Vandevenne","year":"2011","unstructured":"Vandevenne, P. et al. The varicella-zoster virus ORF47 kinase interferes with host innate immune response by inhibiting the activation of IRF3. PLoS ONE 6, e16870 (2011).","journal-title":"PLoS ONE"},{"key":"735_CR100","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1128\/JVI.01450-09","volume":"84","author":"JH Huch","year":"2010","unstructured":"Huch, J. H. et al. Impact of varicella-zoster virus on dendritic cell subsets in human skin during natural infection. J. Virol. 84, 4060\u20134072 (2010).","journal-title":"J. Virol."},{"key":"735_CR101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002157","volume":"7","author":"L Wang","year":"2011","unstructured":"Wang, L. et al. Disruption of PML nuclear bodies is mediated by ORF61 SUMO-interacting motifs and required for varicella-zoster virus pathogenesis in skin. PLoS Pathog. 7, e1002157 (2011).","journal-title":"PLoS Pathog."},{"key":"735_CR102","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.1128\/JVI.01956-05","volume":"80","author":"JO Jones","year":"2006","unstructured":"Jones, J. O. & Arvin, A. M. Inhibition of the NF-kB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo. J. Virol. 80, 5113\u20135124 (2006).","journal-title":"J. Virol."},{"key":"735_CR103","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1128\/JVI.06400-11","volume":"86","author":"E Sloan","year":"2012","unstructured":"Sloan, E., Henriquez, R., Kinchington, P. R., Slobedman, B. & Abendroth, A. Varicella-zoster virus inhibition of the NF-kB pathway during infection of human dendritic cells: role for open reading frame 61 as a modulator of NF-kB activity. J. Virol. 86, 1193\u20131202 (2012).","journal-title":"J. Virol."},{"key":"735_CR104","doi-asserted-by":"publisher","first-page":"8687","DOI":"10.1128\/JVI.01149-15","volume":"89","author":"T Whitmer","year":"2015","unstructured":"Whitmer, T. et al. The ORF61 protein encoded by simian varicella virus and varicella-zoster virus inhibits NF-kB signaling by interfering with IkB\u03b1 degradation. J. Virol. 89, 8687\u20138700 (2015).","journal-title":"J. Virol."},{"key":"735_CR105","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00848-24","volume":"98","author":"CS Niemeyer","year":"2024","unstructured":"Niemeyer, C. S. et al. Suppression of the host antiviral response by non-infectious varicella zoster virus extracellular vesicles. J. Virol. 98, e0084824 (2024).","journal-title":"J. Virol."},{"key":"735_CR106","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1128\/JVI.75.10.4878-4888.2001","volume":"75","author":"A Abendroth","year":"2001","unstructured":"Abendroth, A., Lin, I., Slobedman, B., Ploegh, H. & Arvin, A. M. Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells. J. Virol. 75, 4878\u20134888 (2001).","journal-title":"J. Virol."},{"key":"735_CR107","doi-asserted-by":"publisher","first-page":"9034","DOI":"10.1128\/JVI.00711-07","volume":"81","author":"AJ Eisfeld","year":"2007","unstructured":"Eisfeld, A. J., Yee, M. B., Erazo, A., Abendroth, A. & Kinchington, P. R. Downregulation of class I major histocompatibility complex surface expression by varicella-zoster virus involves open reading frame 66 protein kinase-dependent and -independent mechanisms. J. Virol. 81, 9034\u20139049 (2007).","journal-title":"J. Virol."},{"key":"735_CR108","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007650","volume":"15","author":"D Jones","year":"2019","unstructured":"Jones, D. et al. Varicella zoster virus productively infects human peripheral blood mononuclear cells to modulate expression of immunoinhibitory proteins and blocking PD-L1 enhances virus-specific CD8+ T cell effector function. PLoS Pathog. 15, e1007650 (2019).","journal-title":"PLoS Pathog."},{"key":"735_CR109","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1128\/JVI.74.4.1900-1907.2000","volume":"74","author":"A Abendroth","year":"2000","unstructured":"Abendroth, A. et al. Modulation of major histocompatibility class II protein expression by varicella-zoster virus. J. Virol. 74, 1900\u20131907 (2000).","journal-title":"J. Virol."},{"key":"735_CR110","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/00000372-200402000-00005","volume":"26","author":"AF Nikkels","year":"2004","unstructured":"Nikkels, A. F., Sadzot-Delvaux, C. & Pierard, G. E. Absence of intercellular adhesion molecule 1 expression in varicella zoster virus-infected keratinocytes during herpes zoster: another immune evasion strategy? Am. J. Dermatopathol. 26, 27\u201332 (2004).","journal-title":"Am. J. Dermatopathol."},{"key":"735_CR111","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1099\/jgv.0.000925","volume":"98","author":"WJD Ouwendijk","year":"2017","unstructured":"Ouwendijk, W. J. D., van Veen, S., Mahalingam, R. & Verjans, G. Simian varicella virus inhibits the interferon gamma signalling pathway. J. Gen. Virol. 98, 2582\u20132588 (2017).","journal-title":"J. Gen. Virol."},{"key":"735_CR112","doi-asserted-by":"publisher","first-page":"7932","DOI":"10.1128\/JVI.00292-15","volume":"89","author":"TM Campbell","year":"2015","unstructured":"Campbell, T. M., McSharry, B. P., Steain, M., Slobedman, B. & Abendroth, A. Varicella-zoster virus and herpes simplex virus 1 differentially modulate NKG2D ligand expression during productive infection. J. Virol. 89, 7932\u20137943 (2015).","journal-title":"J. Virol."},{"key":"735_CR113","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/infdis\/jir425","volume":"204","author":"MA Nagel","year":"2011","unstructured":"Nagel, M. A. et al. Persistence of varicella zoster virus DNA in saliva after herpes zoster. J. Infect. Dis. 204, 820\u2013824 (2011).","journal-title":"J. Infect. Dis."},{"key":"735_CR114","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1212\/01.wnl.0000438228.48470.86","volume":"82","author":"M Birlea","year":"2014","unstructured":"Birlea, M. et al. Varicella-zoster virus trigeminal ganglioneuritis without rash. Neurology 82, 90\u201392 (2014).","journal-title":"Neurology"},{"key":"735_CR115","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.3389\/fmicb.2019.02117","volume":"10","author":"JP Sutherland","year":"2019","unstructured":"Sutherland, J. P. et al. Persistence of a T cell infiltrate in human ganglia years after herpes zoster and during post-herpetic neuralgia. Front. Microbiol. 10, 2117 (2019).","journal-title":"Front. Microbiol."},{"key":"735_CR116","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0304-3959(91)90124-G","volume":"44","author":"CPN Watson","year":"1991","unstructured":"Watson, C. P. N., Deck, J. H., Morshead, C., Van der Kooy, D. & Evans, R. J. Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 44, 105\u2013117 (1991).","journal-title":"Pain"},{"key":"735_CR117","first-page":"50","volume":"10","author":"FP Smith","year":"1978","unstructured":"Smith, F. P. Pathological studies of spinal nerve ganglia in relation to intractable intercostal pain. Surg. Neurol. 10, 50\u201353 (1978).","journal-title":"Surg. Neurol."},{"key":"735_CR118","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1128\/JVI.02592-07","volume":"82","author":"M Reichelt","year":"2008","unstructured":"Reichelt, M., Zerboni, L. & Arvin, A. M. Mechanisms of varicella-zoster virus neuropathogenesis in human dorsal root ganglia. J. Virol. 82, 3971\u20133983 (2008).","journal-title":"J. Virol."},{"key":"735_CR119","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3109\/13550289509111018","volume":"1","author":"R Mahalingam","year":"1995","unstructured":"Mahalingam, R., Wellish, M., Brucklier, J. & Gilden, D. H. Persistence of varicella-zoster virus DNA in elderly patients with postherpetic neuralgia. J. Neurovirol 1, 130\u2013133 (1995).","journal-title":"J. Neurovirol"},{"key":"735_CR120","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1073\/pnas.85.8.2767","volume":"85","author":"A Vafai","year":"1988","unstructured":"Vafai, A., Wellish, M. & Gilden, D. H. Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia. Proc. Natl Acad. Sci. USA 85, 2767\u20132770 (1988).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"735_CR121","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/ana.410350505","volume":"35","author":"DH Gilden","year":"1994","unstructured":"Gilden, D. H., Wright, R. R., Schneck, S. A., Gwaltney, J. M. Jr & Mahalingam, R. Zoster sine herpete, a clinical variant. Ann. Neurol. 35, 530\u2013533 (1994).","journal-title":"Ann. Neurol."},{"key":"735_CR122","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S1474-4422(03)00506-4","volume":"2","author":"R Hevner","year":"2003","unstructured":"Hevner, R. et al. An unusual cause of trigeminal-distribution pain and tumour. Lancet Neurol. 2, 567\u2013571 (2003).","journal-title":"Lancet Neurol."},{"key":"735_CR123","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/archneur.63.7.noc60049","volume":"63","author":"D Quan","year":"2006","unstructured":"Quan, D., Hammack, B. N., Kittelson, J. & Gilden, D. H. Improvement of postherpetic neuralgia after treatment with intravenous acyclovir followed by oral valacyclovir. Arch. Neurol. 63, 940\u2013942 (2006).","journal-title":"Arch. Neurol."},{"key":"735_CR124","volume":"2014","author":"N Chen","year":"2014","unstructured":"Chen, N. et al. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst. Rev. 2014, CD006866 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"key":"735_CR125","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1001\/jamaophthalmol.2024.6113","volume":"143","author":"DB Warner","year":"2025","unstructured":"Warner, D. B. et al. Low-dose valacyclovir for postherpetic neuralgia in the zoster eye disease study: a randomized clinical trial. JAMA Ophthalmol. 143, 277\u2013285 (2025).","journal-title":"JAMA Ophthalmol."},{"key":"735_CR126","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0304-3959(00)00481-4","volume":"92","author":"AL Oaklander","year":"2001","unstructured":"Oaklander, A. L. The density of remaining nerve endings in human skin with and without postherpetic neuralgia after shingles. Pain 92, 139\u2013145 (2001).","journal-title":"Pain"},{"key":"735_CR127","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.pain.2010.04.002","volume":"150","author":"KL Petersen","year":"2010","unstructured":"Petersen, K. L., Rice, F. L., Farhadi, M., Reda, H. & Rowbotham, M. C. Natural history of cutaneous innervation following herpes zoster. Pain 150, 75\u201382 (2010).","journal-title":"Pain"},{"key":"735_CR128","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1006\/nbdi.1996.0021","volume":"3","author":"MC Rowbotham","year":"1996","unstructured":"Rowbotham, M. C. et al. Cutaneous innervation density in the allodynic form of postherpetic neuralgia. Neurobiol. Dis. 3, 205\u2013214 (1996).","journal-title":"Neurobiol. Dis."},{"key":"735_CR129","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263831","volume":"17","author":"SS Gylfadottir","year":"2022","unstructured":"Gylfadottir, S. S. et al. The characteristics of pain and dysesthesia in patients with diabetic polyneuropathy. PLoS ONE 17, e0263831 (2022).","journal-title":"PLoS ONE"},{"key":"735_CR130","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2337\/diacare.29.04.06.dc05-2180","volume":"29","author":"L Sorensen","year":"2006","unstructured":"Sorensen, L., Molyneaux, L. & Yue, D. K. The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care 29, 883\u2013887 (2006).","journal-title":"Diabetes Care"},{"key":"735_CR131","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.pain.2014.01.022","volume":"155","author":"A Truini","year":"2014","unstructured":"Truini, A. et al. Does the epidermal nerve fibre density measured by skin biopsy in patients with peripheral neuropathies correlate with neuropathic pain? Pain 155, 828\u2013832 (2014).","journal-title":"Pain"},{"key":"735_CR132","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1006\/nbdi.1998.0204","volume":"5","author":"HL Fields","year":"1998","unstructured":"Fields, H. L., Rowbotham, M. & Baron, R. Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiol. Dis. 5, 209\u2013227 (1998).","journal-title":"Neurobiol. Dis."},{"key":"735_CR133","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-016-0548-x","volume":"20","author":"GR Hadley","year":"2016","unstructured":"Hadley, G. R. et al. Post-herpetic neuralgia: a review. Curr. Pain. Headache Rep. 20, 17 (2016).","journal-title":"Curr. Pain. Headache Rep."},{"key":"735_CR134","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/00000542-200107000-00034","volume":"95","author":"CJ Woolf","year":"2001","unstructured":"Woolf, C. J. & Max, M. B. Mechanism-based pain diagnosis: issues for analgesic drug development. Anesthesiology 95, 241\u2013249 (2001).","journal-title":"Anesthesiology"},{"key":"735_CR135","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1212\/01.wnl.0000258549.13334.16","volume":"68","author":"MA Nagel","year":"2007","unstructured":"Nagel, M. A. et al. The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology 68, 1069\u20131073 (2007).","journal-title":"Neurology"},{"key":"735_CR136","volume":"14","author":"HJ Fullerton","year":"2025","unstructured":"Fullerton, H. J. et al. Evidence of varicella zoster virus reactivation in children with arterial ischemic stroke: results of the VIPS II study. J. Am. Heart Assoc. 14, e039184 (2025).","journal-title":"J. Am. Heart Assoc."},{"key":"735_CR137","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1212\/WNL.0000000000001409","volume":"84","author":"D Gilden","year":"2015","unstructured":"Gilden, D. et al. Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology 84, 1948\u20131955 (2015).","journal-title":"Neurology"},{"key":"735_CR138","doi-asserted-by":"publisher","first-page":"e1078","DOI":"10.1212\/NXI.0000000000001078","volume":"8","author":"AN Bubak","year":"2021","unstructured":"Bubak, A. N. et al. Targeted RNA sequencing of formalin-fixed, paraffin-embedded temporal arteries from giant cell arteritis cases reveals viral signatures. Neurol. Neuroimmunol. Neuroinflamm.\u00a08, e1078 https:\/\/doi.org\/10.1212\/NXI.0000000000001078 (2021).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"735_CR139","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jcv.2015.03.016","volume":"66","author":"MA Nagel","year":"2015","unstructured":"Nagel, M. A. et al. Disseminated VZV infection and asymptomatic VZV vasculopathy after steroid abuse. J. Clin. Virol. 66, 72\u201375 (2015).","journal-title":"J. Clin. Virol."},{"key":"735_CR140","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3899\/jrheum.180912","volume":"46","author":"IH Solomon","year":"2019","unstructured":"Solomon, I. H., Docken, W. P. & Padera, R. F. Jr. Investigating the association of giant cell arteritis with varicella zoster virus in temporal artery biopsies or ascending aortic resections. J. Rheumatol. 46, 1614\u20131618 (2019).","journal-title":"J. Rheumatol."},{"key":"735_CR141","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/infdis\/jiaa566","volume":"223","author":"RM Verdijk","year":"2021","unstructured":"Verdijk, R. M., Ouwendijk, W. J. D., Kuijpers, R. & Verjans, G. No evidence of varicella-zoster virus infection in temporal artery biopsies of anterior ischemic optic neuropathy patients with and without giant cell arteritis. J. Infect. Dis. 223, 109\u2013112 (2021).","journal-title":"J. Infect. Dis."},{"key":"735_CR142","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/infdis\/jiac405","volume":"227","author":"AN Bubak","year":"2023","unstructured":"Bubak, A. N. et al. Zoster-associated prothrombotic plasma exosomes and increased stroke risk. J. Infect. Dis. 227, 993\u20131001 (2023).","journal-title":"J. Infect. Dis."},{"key":"735_CR143","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000382","volume":"4","author":"D Jones","year":"2017","unstructured":"Jones, D., Neff, C. P., Palmer, B. E., Stenmark, K. & Nagel, M. A. Varicella zoster virus-infected cerebrovascular cells produce a proinflammatory environment. Neurol. Neuroimmunol. Neuroinflamm. 4, e382 (2017).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"735_CR144","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000246","volume":"3","author":"D Jones","year":"2016","unstructured":"Jones, D., Alvarez, E., Selva, S., Gilden, D. & Nagel, M. A. Proinflammatory cytokines and matrix metalloproteinases in CSF of patients with VZV vasculopathy. Neurol. Neuroimmunol. Neuroinflamm. 3, e246 (2016).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"735_CR145","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1093\/infdis\/jiaa513","volume":"223","author":"AN Bubak","year":"2021","unstructured":"Bubak, A. N. et al. Amylin, A\u03b242, and amyloid in varicella zoster virus vasculopathy cerebrospinal fluid and infected vascular cells. J. Infect. Dis. 223, 1284\u20131294 (2021).","journal-title":"J. Infect. Dis."},{"key":"735_CR146","doi-asserted-by":"publisher","first-page":"e1103","DOI":"10.1212\/NXI.0000000000001103","volume":"9","author":"AN Bubak","year":"2022","unstructured":"Bubak, A. N. et al. Targeted RNA sequencing of VZV-infected brain vascular adventitial fibroblasts indicates that amyloid may be involved in VZV vasculopathy. Neurol. Neuroimmunol. Neuroinflamm. 9, e1103 https:\/\/doi.org\/10.1212\/NXI.0000000000001103 (2022).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"735_CR147","doi-asserted-by":"publisher","first-page":"909","DOI":"10.5692\/clinicalneurol.cn-002146","volume":"65","author":"Y Hattori","year":"2025","unstructured":"Hattori, Y. et al. Delayed onset of diplopia and visual impairment after herpes zoster ophthalmicus [Japanese]. Rinsho Shinkeigaku 65, 909\u2013911 https:\/\/doi.org\/10.5692\/clinicalneurol.cn-002146 (2025).","journal-title":"Rinsho Shinkeigaku"},{"key":"735_CR148","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-215953","author":"MA Nagel","year":"2016","unstructured":"Nagel, M. A. & Gilden, D. Burning mouth syndrome associated with varicella zoster virus. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2016-215953 (2016).","journal-title":"BMJ Case Rep."},{"key":"735_CR149","first-page":"241","volume":"62","author":"K Pushpanshu","year":"2013","unstructured":"Pushpanshu, K., Kaushik, R., Srivastava, S. & Punyani, S. R. An unusual complication of tooth exfoliation and osteonecrosis following herpes zoster infection of trigeminal nerve: a case report and literature review. Minerva Stomatol. 62, 241\u2013245 (2013).","journal-title":"Minerva Stomatol."},{"key":"735_CR150","doi-asserted-by":"publisher","first-page":"6206","DOI":"10.3390\/jcm12196206","volume":"12","author":"R Teggi","year":"2023","unstructured":"Teggi, R. et al. Cochleo-vestibular disorders in herpes zoster oticus: a literature review and a case of bilateral vestibular hypofunction in unilateral HZO. J. Clin. Med. 12, 6206\u00a0https:\/\/doi.org\/10.3390\/jcm12196206 (2023).","journal-title":"J. Clin. Med."},{"key":"735_CR151","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.4314\/ahs.v19i3.6","volume":"19","author":"P Apiyo","year":"2019","unstructured":"Apiyo, P. & Hajek, J. Herpes zoster complicated by phrenic nerve palsy and respiratory compromise. Afr. Health Sci. 19, 2347\u20132350 (2019).","journal-title":"Afr. Health Sci."},{"key":"735_CR152","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1212\/WNL.86.16_supplement.P1.296","volume":"86","author":"J Grayson","year":"2016","unstructured":"Grayson, J., Kaur, S. & Malaty, I. Hemidiaphragmatic paralysis: a rare complication of VZV (P1. 296). Neurology 86, 296 (2016).","journal-title":"Neurology"},{"key":"735_CR153","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1212\/01.wnl.0000266390.27177.7b","volume":"69","author":"HT Orme","year":"2007","unstructured":"Orme, H. T. et al. VZV spinal cord infarction identified by diffusion-weighted MRI (DWI). Neurology 69, 398\u2013400 (2007).","journal-title":"Neurology"},{"key":"735_CR154","doi-asserted-by":"publisher","first-page":"16m11312","DOI":"10.4088\/JCP.16m11312","volume":"79","author":"VC Chen","year":"2018","unstructured":"Chen, V. C. et al. Herpes zoster and dementia: a nationwide population-based cohort study. J. Clin. Psychiatry 79, 16m11312 https:\/\/doi.org\/10.4088\/JCP.16m11312 (2018).","journal-title":"J. Clin. Psychiatry"},{"key":"735_CR155","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41586-025-08800-x","volume":"641","author":"M Eyting","year":"2025","unstructured":"Eyting, M. et al. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature 641, 438\u2013446 (2025).","journal-title":"Nature"},{"key":"735_CR156","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.21873\/invivo.12622","volume":"35","author":"S Lehrer","year":"2021","unstructured":"Lehrer, S. & Rheinstein, P. H. Herpes zoster vaccination reduces risk of dementia. Vivo 35, 3271\u20133275 (2021).","journal-title":"Vivo"},{"key":"735_CR157","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.neuron.2022.12.029","volume":"111","author":"KS Levine","year":"2023","unstructured":"Levine, K. S. et al. Virus exposure and neurodegenerative disease risk across national biobanks. Neuron 111, 1086\u20131093.e2\u00a0https:\/\/doi.org\/10.1016\/j.neuron.2022.12.029 (2023).","journal-title":"Neuron"},{"key":"735_CR158","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-045871","volume":"11","author":"A Lophatananon","year":"2021","unstructured":"Lophatananon, A. et al. Shingles, zostavax vaccination and risk of developing dementia: a nested case-control study-results from the UK Biobank cohort. BMJ Open 11, e045871 (2021).","journal-title":"BMJ Open"},{"key":"735_CR159","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1038\/s41591-025-03972-5","volume":"31","author":"V Polisky","year":"2025","unstructured":"Polisky, V. et al. Varicella-zoster virus reactivation and the risk of dementia. Nat. Med. 31, 4172\u20134179 https:\/\/doi.org\/10.1038\/s41591-025-03972-5 (2025).","journal-title":"Nat. Med."},{"key":"735_CR160","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12293","volume":"8","author":"C Schnier","year":"2022","unstructured":"Schnier, C., Janbek, J., Lathe, R. & Haas, J. Reduced dementia incidence after varicella zoster vaccination in Wales 2013\u20132020. Alzheimer\u2019s Dement. 8, e12293 (2022).","journal-title":"Alzheimer\u2019s Dement."},{"key":"735_CR161","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188490","volume":"12","author":"MC Tsai","year":"2017","unstructured":"Tsai, M. C. et al. Increased risk of dementia following herpes zoster ophthalmicus. PLoS ONE 12, e0188490 (2017).","journal-title":"PLoS ONE"},{"key":"735_CR162","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000034503","volume":"102","author":"RH Elhalag","year":"2023","unstructured":"Elhalag, R. H. et al. Herpes zoster virus infection and the risk of developing dementia: a systematic review and meta-analysis. Medicine 102, e34503 (2023).","journal-title":"Medicine"},{"key":"735_CR163","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s13365-024-01196-w","volume":"30","author":"CS Niemeyer","year":"2024","unstructured":"Niemeyer, C. S. et al. Simian varicella virus infection and reactivation in rhesus macaques trigger cytokine and A\u03b240\/42 alterations in serum and cerebrospinal fluid. J. Neurovirol. 30, 86\u201399 (2024).","journal-title":"J. Neurovirol."},{"key":"735_CR164","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s13365-020-00830-7","volume":"26","author":"AN Bubak","year":"2020","unstructured":"Bubak, A. N. et al. Acute zoster plasma contains elevated amyloid, correlating with A\u03b242 and amylin levels, and is amyloidogenic. J. Neurovirol. 26, 422\u2013428 (2020).","journal-title":"J. Neurovirol."},{"key":"735_CR165","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/infdis\/jiz560","volume":"221","author":"AN Bubak","year":"2020","unstructured":"Bubak, A. N. et al. Varicella-zoster virus infection of primary human spinal astrocytes produces intracellular amylin, amyloid-\u03b2, and an amyloidogenic extracellular environment. J. Infect. Dis. 221, 1088\u20131097 (2020).","journal-title":"J. Infect. Dis."},{"key":"735_CR166","doi-asserted-by":"publisher","first-page":"5988","DOI":"10.1021\/bi000029f","volume":"39","author":"DH Cribbs","year":"2000","unstructured":"Cribbs, D. H., Azizeh, B. Y., Cotman, C. W. & LaFerla, F. M. Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer\u2019s A\u03b2 peptide. Biochemistry 39, 5988\u20135994 (2000).","journal-title":"Biochemistry"},{"key":"735_CR167","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.febslet.2014.03.016","volume":"588","author":"S Tan","year":"2014","unstructured":"Tan, S. et al. Peptides derived from HIV-1 gp120 co-receptor binding domain form amyloid fibrils and enhance HIV-1 infection. FEBS Lett. 588, 1515\u20131522 (2014).","journal-title":"FEBS Lett."},{"key":"735_CR168","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/QCO.0000000000000647","volume":"33","author":"MA Nagel","year":"2020","unstructured":"Nagel, M. A., Niemeyer, C. S. & Bubak, A. N. Central nervous system infections produced by varicella zoster virus. Curr. Opin. Infect. Dis. 33, 273\u2013278 (2020).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"735_CR169","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1212\/WNL.0b013e31827b1ab9","volume":"80","author":"MA Nagel","year":"2013","unstructured":"Nagel, M. A. et al. Varicella-zoster virus vasculopathy: immune characteristics of virus-infected arteries. Neurology 80, 62\u201368 (2013).","journal-title":"Neurology"},{"key":"735_CR170","doi-asserted-by":"publisher","first-page":"117315","DOI":"10.1016\/j.jns.2021.117315","volume":"422","author":"T Mescher","year":"2021","unstructured":"Mescher, T., Boyer, P. J., Bubak, A. N., Hassell, J. E. Jr & Nagel, M. A. Detection of varicella zoster virus antigen and DNA in two cases of cerebral amyloid angiopathy. J. Neurol. Sci. 422, 117315 (2021).","journal-title":"J. Neurol. Sci."},{"key":"735_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127274","volume":"59","author":"F Hattori","year":"2025","unstructured":"Hattori, F. et al. Epidemiology and clinical features of breakthrough varicella in the 9 years after universal vaccination began in Japan. Vaccine 59, 127274 (2025).","journal-title":"Vaccine"},{"key":"735_CR172","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/S0264-410X(98)00137-6","volume":"16","author":"K Schmader","year":"1998","unstructured":"Schmader, K. Postherpetic neuralgia in immunocompetent elderly people. Vaccine 16, 1768\u20131770 (1998).","journal-title":"Vaccine"},{"key":"735_CR173","unstructured":"Gruver, C. & Guthmiller, K. B. Postherpetic neuralgia. StatPearls (2026)."},{"key":"735_CR174","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-004833","volume":"4","author":"K Kawai","year":"2014","unstructured":"Kawai, K., Gebremeskel, B. G. & Acosta, C. J. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open 4, e004833 (2014).","journal-title":"BMJ Open"},{"key":"735_CR175","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ijid.2015.03.022","volume":"34","author":"K Kawai","year":"2015","unstructured":"Kawai, K. et al. Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from North and Latin America and Asia. Int. J. Infect. Dis. 34, 126\u2013131 (2015).","journal-title":"Int. J. Infect. Dis."},{"key":"735_CR176","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/cid\/civ320","volume":"61","author":"AA Gershon","year":"2015","unstructured":"Gershon, A. A., Chen, J. & Gershon, M. D. Use of saliva to identify varicella zoster virus infection of the gut. Clin. Infect. Dis. 61, 536\u2013544 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"735_CR177","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2482286","volume":"21","author":"C Tommasi","year":"2025","unstructured":"Tommasi, C., Drousioti, A. & Breuer, J. The live attenuated varicella-zoster virus vaccine vOka: molecular and cellular biology of its skin attenuation. Hum. Vaccin. Immunother. 21, 2482286 (2025).","journal-title":"Hum. Vaccin. Immunother."},{"key":"735_CR178","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","volume":"2","author":"M Takahashi","year":"1974","unstructured":"Takahashi, M., Otsuka, T., Okuno, Y., Asano, Y. & Yazaki, T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 2, 1288\u20131290 (1974).","journal-title":"Lancet"},{"key":"735_CR179","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/2051013613515621","volume":"2","author":"O Papaloukas","year":"2014","unstructured":"Papaloukas, O., Giannouli, G. & Papaevangelou, V. Successes and challenges in varicella vaccine. Ther. Adv. Vaccines 2, 39\u201355 (2014).","journal-title":"Ther. Adv. Vaccines"},{"key":"735_CR180","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/BF02723143","volume":"70","author":"SY Bhave","year":"2003","unstructured":"Bhave, S. Y. Controversies in chicken-pox immunization. Indian J. Pediatr. 70, 503\u2013507 (2003).","journal-title":"Indian J. Pediatr."},{"key":"735_CR181","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3345\/cep.2021.01564","volume":"65","author":"YH Lee","year":"2022","unstructured":"Lee, Y. H. et al. Global varicella vaccination programs. Clin. Exp. Pediatr. 65, 555\u2013562 (2022).","journal-title":"Clin. Exp. Pediatr."},{"key":"735_CR182","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2328955","volume":"20","author":"P Srikanth","year":"2024","unstructured":"Srikanth, P. et al. Expanded spectrum of varicella disease and the need for vaccination in India. Hum. Vaccin. Immunother. 20, 2328955 (2024).","journal-title":"Hum. Vaccin. Immunother."},{"key":"735_CR183","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0022-3476(05)83173-7","volume":"124","author":"DM Huse","year":"1994","unstructured":"Huse, D. M., Meissner, H. C., Lacey, M. J. & Oster, G. Childhood vaccination against chickenpox: an analysis of benefits and costs. J. Pediatr. 124, 869\u2013874 (1994).","journal-title":"J. Pediatr."},{"key":"735_CR184","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/INF.0000000000001356","volume":"36","author":"A Streng","year":"2017","unstructured":"Streng, A., Grote, V., Rack-Hoch, A. & Liese, J. G. Decline of neurologic varicella complications in children during the first seven years after introduction of universal varicella vaccination in Germany, 2005\u20132011. Pediatr. Infect. Dis. J. 36, 79\u201386 (2017).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"735_CR185","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2278927","volume":"19","author":"KU Miranda","year":"2023","unstructured":"Miranda, K. U., DeAntonio, R., Norero, X. & Estripeaut, D. The impact of varicella vaccination: a 2005\u20132019 interrupted time series analysis. Hum. Vaccin. Immunother. 19, 2278927 (2023).","journal-title":"Hum. Vaccin. Immunother."},{"key":"735_CR186","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1080\/21645515.2018.1546525","volume":"15","author":"FH Varela","year":"2019","unstructured":"Varela, F. H., Pinto, L. A. & Scotta, M. C. Global impact of varicella vaccination programs. Hum. Vaccin. Immunother. 15, 645\u2013657 (2019).","journal-title":"Hum. Vaccin. Immunother."},{"key":"735_CR187","doi-asserted-by":"publisher","first-page":"874","DOI":"10.4161\/hv.7.8.15685","volume":"7","author":"R Verma","year":"2011","unstructured":"Verma, R., Bairwa, M., Chawla, S., Prinja, S. & Rajput, M. Should the chickenpox vaccine be included in the national immunization schedule in India? Hum. Vaccin. 7, 874\u2013877 (2011).","journal-title":"Hum. Vaccin."},{"key":"735_CR188","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1080\/14760584.2020.1825947","volume":"19","author":"F Kauffmann","year":"2020","unstructured":"Kauffmann, F., Bechini, A., Bonanni, P., Casabona, G. & Wutzler, P. Varicella vaccination in Italy and Germany \u2014 different routes to success: a systematic review. Expert Rev. Vaccines 19, 843\u2013869 (2020).","journal-title":"Expert Rev. Vaccines"},{"key":"735_CR189","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/INF.0000000000002233","volume":"38","author":"V Spoulou","year":"2019","unstructured":"Spoulou, V. et al. Implementing universal varicella vaccination in europe: the path forward. Pediatr. Infect. Dis. J. 38, 181\u2013188 (2019).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"735_CR190","doi-asserted-by":"publisher","first-page":"S392","DOI":"10.1093\/infdis\/jiac221","volume":"226","author":"M Marin","year":"2022","unstructured":"Marin, M., Leung, J., Anderson, T. C. & Lopez, A. S. Monitoring varicella vaccine impact on varicella incidence in the United States: surveillance challenges and changing epidemiology, 1995\u20132019. J. Infect. Dis. 226, S392\u2013S399 (2022).","journal-title":"J. Infect. Dis."},{"key":"735_CR191","doi-asserted-by":"publisher","first-page":"S470","DOI":"10.1093\/infdis\/jiac255","volume":"226","author":"J Leung","year":"2022","unstructured":"Leung, J., Dooling, K., Marin, M., Anderson, T. C. & Harpaz, R. The impact of universal varicella vaccination on herpes zoster incidence in the United States: comparison of birth cohorts preceding and following varicella vaccination program launch. J. Infect. Dis. 226, S470\u2013S477 (2022).","journal-title":"J. Infect. Dis."},{"key":"735_CR192","doi-asserted-by":"publisher","first-page":"4936","DOI":"10.1016\/j.vaccine.2017.07.090","volume":"35","author":"F Hattori","year":"2017","unstructured":"Hattori, F. et al. Evaluating the effectiveness of the universal immunization program against varicella in Japanese children. Vaccine 35, 4936\u20134941 (2017).","journal-title":"Vaccine"},{"key":"735_CR193","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1016\/j.vaccine.2011.01.092","volume":"29","author":"WC Huang","year":"2011","unstructured":"Huang, W. C., Huang, L. M., Chang, I. S., Tsai, F. Y. & Chang, L. Y. Varicella breakthrough infection and vaccine effectiveness in Taiwan. Vaccine 29, 2756\u20132760 (2011).","journal-title":"Vaccine"},{"key":"735_CR194","first-page":"RR-4","volume":"56","author":"M Marin","year":"2007","unstructured":"Marin, M., G\u00fcris, D., Chaves, S. S., Schmid, S. & Seward, J. F. Prevention of varicella. recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbid. Mortal. Wkly Rep. 56, RR-4 (2007).","journal-title":"Morbid. Mortal. Wkly Rep."},{"key":"735_CR195","unstructured":"Centers for Disease Control and Prevention. Varicella vaccine recommendations: information for healthcare professionals. CDC https:\/\/www.cdc.gov\/chickenpox\/hcp\/vaccine-considerations\/index.html (2024)."},{"key":"735_CR196","unstructured":"Centers for Disease Control and Prevention. Shingles vaccine recommendations: information for healthcare professionals. CDC https:\/\/www.cdc.gov\/shingles\/hcp\/vaccine-considerations\/index.html (2024)."},{"key":"735_CR197","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman, M. N. et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N. Engl. J. Med. 352, 2271\u20132284 (2005).","journal-title":"N. Engl. J. Med."},{"key":"735_CR198","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3390\/vaccines13101073","volume":"13","author":"M Chiavarini","year":"2025","unstructured":"Chiavarini, M. et al. Vaccination against herpes zoster in adults: current strategies in European Union countries. Vaccines 13, 1073 https:\/\/doi.org\/10.3390\/vaccines13101073 (2025).","journal-title":"Vaccines"},{"key":"735_CR199","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0002-9343(82)90055-9","volume":"73","author":"GB Elion","year":"1982","unstructured":"Elion, G. B. Mechanism of action and selectivity of acyclovir. Am. J. Med. 73, 7\u201313 (1982).","journal-title":"Am. J. Med."},{"key":"735_CR200","first-page":"518","volume":"19","author":"C Fletcher","year":"1985","unstructured":"Fletcher, C. & Bean, B. Evaluation of oral acyclovir therapy. Drug Intell. Clin. Pharm. 19, 518\u2013524 (1985).","journal-title":"Drug Intell. Clin. Pharm."},{"key":"735_CR201","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1128\/AAC.39.12.2759","volume":"39","author":"J Soul-Lawton","year":"1995","unstructured":"Soul-Lawton, J. et al. Absolute bioavailability and metabolic disposition of valaciclovir, the l-valyl ester of acyclovir, following oral administration to humans. Antimicrob. Agents Chemother. 39, 2759\u20132764 (1995).","journal-title":"Antimicrob. Agents Chemother."},{"key":"735_CR202","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/095632029300400201","volume":"4","author":"RV Hodge","year":"1993","unstructured":"Hodge, R. V. Famciclovir and penciclovir. The mode of action of famciclovir including its conversion to penciclovir. Antivir. Chem. Chemother. 4, 67\u201384 (1993).","journal-title":"Antivir. Chem. Chemother."},{"issue":"Suppl. 1","key":"735_CR203","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1086\/510206","volume":"44","author":"RH Dworkin","year":"2007","unstructured":"Dworkin, R. H. et al. Recommendations for the management of herpes zoster. Clin. Infect. Dis. 44 (Suppl. 1), S1\u2013S26 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"735_CR204","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1128\/AAC.18.3.443","volume":"18","author":"KK Biron","year":"1980","unstructured":"Biron, K. K. & Elion, G. B. In vitro susceptibility of varicella-zoster virus to acyclovir. Antimicrob. Agents Chemother. 18, 443\u2013447 (1980).","journal-title":"Antimicrob. Agents Chemother."},{"key":"735_CR205","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0002-9343(82)90128-0","volume":"73","author":"KK Biron","year":"1982","unstructured":"Biron, K. K., Fyfe, J. A., Noblin, J. E. & Elion, G. B. Selection and preliminary characterization of acyclovir-resistant mutants of varicella zoster virus. Am. J. Med. 73, 383\u2013386 (1982).","journal-title":"Am. J. Med."},{"key":"735_CR206","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1128\/AAC.43.10.2412","volume":"43","author":"F Morfin","year":"1999","unstructured":"Morfin, F. et al. Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir. Antimicrob. Agents Chemother. 43, 2412\u20132416 (1999).","journal-title":"Antimicrob. Agents Chemother."},{"key":"735_CR207","doi-asserted-by":"publisher","first-page":"ofac494","DOI":"10.1093\/ofid\/ofac494","volume":"9","author":"M Kawashima","year":"2022","unstructured":"Kawashima, M., Imafuku, S., Fujio, K. & Komazaki, H. Single-dose, patient-initiated amenamevir therapy for recurrent genital herpes: a phase 3, randomized, double-blind, placebo-controlled study. Open Forum Infect. Dis. 9, ofac494 (2022).","journal-title":"Open Forum Infect. Dis."},{"key":"735_CR208","unstructured":"Taylor, M. & Gerriets, V. Acyclovir. StatPearls (2024)."},{"key":"735_CR209","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3390\/v14020192","volume":"14","author":"A Patil","year":"2022","unstructured":"Patil, A., Goldust, M. & Wollina, U. Herpes zoster: a review of clinical manifestations and management. Viruses 14, 192 https:\/\/doi.org\/10.3390\/v14020192 (2022).","journal-title":"Viruses"},{"key":"735_CR210","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/jcpt.13464","volume":"46","author":"D Brandariz-Nunez","year":"2021","unstructured":"Brandariz-Nu\u00f1ez, D., Correas-Sanahuja, M., Maya-Gallego, S. & Mart\u00edn Herranz, I. Neurotoxicity associated with acyclovir and valacyclovir: a systematic review of cases. J. Clin. Pharm. Ther. 46, 918\u2013926 (2021).","journal-title":"J. Clin. Pharm. Ther."},{"key":"735_CR211","unstructured":"Garikapati, S. & Nguyen, M. Foscarnet. StatPearls (2024)."},{"key":"735_CR212","unstructured":"Centers for Disease Control and Prevention. How to treat chickenpox. CDC (2024)."},{"key":"735_CR213","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.cger.2016.02.011","volume":"32","author":"K Schmader","year":"2016","unstructured":"Schmader, K. Herpes zoster. Clin. Geriatr. Med. 32, 539\u2013553 (2016).","journal-title":"Clin. Geriatr. Med."},{"key":"735_CR214","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.idc.2017.07.016","volume":"31","author":"AR John","year":"2017","unstructured":"John, A. R. & Canaday, D. H. Herpes zoster in the older adult. Infect. Dis. Clin. N. Am. 31, 811\u2013826 (2017).","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"735_CR215","unstructured":"Minor, M., Gurnani, B. & Payne, E. Herpes zoster ophthalmicus. StatPearls (2025)."},{"key":"735_CR216","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005582.pub4","author":"Y Han","year":"2013","unstructured":"Han, Y. et al. Corticosteroids for preventing postherpetic neuralgia. Cochrane Database Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.CD005582.pub4 (2013).","journal-title":"Cochrane Database Syst. Rev."},{"key":"735_CR217","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2445-2","volume":"17","author":"M Riera-Montes","year":"2017","unstructured":"Riera-Montes, M. et al. Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization. BMC Infect. Dis. 17, 353 (2017).","journal-title":"BMC Infect. Dis."},{"key":"735_CR218","doi-asserted-by":"publisher","first-page":"2266225","DOI":"10.1080\/21645515.2023.2266225","volume":"19","author":"I Williame","year":"2023","unstructured":"Williame, I. et al. Healthcare resource use and costs of varicella and its complications: a systematic literature review. Hum. Vaccin. Immunother. 19, 2266225 (2023).","journal-title":"Hum. Vaccin. Immunother."},{"key":"735_CR219","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s40121-024-01002-4","volume":"13","author":"N Giannelos","year":"2024","unstructured":"Giannelos, N. et al. The incidence of herpes zoster complications: a systematic literature review. Infect. Dis. Ther. 13, 1461\u20131486 (2024).","journal-title":"Infect. Dis. Ther."},{"key":"735_CR220","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/j.pain.0000000000001718","volume":"161","author":"M Harvey","year":"2020","unstructured":"Harvey, M., Prosser, L. A., Rose, A. M., Ortega-Sanchez, I. R. & Harpaz, R. Aggregate health and economic burden of herpes zoster in the United States: illustrative example of a pain condition. Pain 161, 361\u2013368 (2020).","journal-title":"Pain"},{"key":"735_CR221","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jpain.2004.06.001","volume":"5","author":"PM Coplan","year":"2004","unstructured":"Coplan, P. M. et al. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J. Pain 5, 344\u2013356 (2004).","journal-title":"J. Pain"},{"key":"735_CR222","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/00002508-200211000-00002","volume":"18","author":"KE Schmader","year":"2002","unstructured":"Schmader, K. E. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin. J. Pain 18, 350\u2013354 (2002).","journal-title":"Clin. J. Pain"},{"key":"735_CR223","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1086\/320169","volume":"32","author":"K Schmader","year":"2001","unstructured":"Schmader, K. Herpes zoster in older adults. Clin. Infect. Dis. 32, 1481\u20131486 (2001).","journal-title":"Clin. Infect. Dis."},{"key":"735_CR224","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1212\/WNL.45.12_Suppl_8.S52","volume":"45","author":"E Lydick","year":"1995","unstructured":"Lydick, E., Epstein, R. S., Himmelberger, D. & White, C. J. Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology 45, S52\u2013S53 (1995).","journal-title":"Neurology"},{"key":"735_CR225","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pediatrneurol.2025.09.015","volume":"173","author":"ND Matoor","year":"2025","unstructured":"Matoor, N. D. et al. Recurrence rate and outcome of varicella-associated childhood stroke: a nationwide population-based study and systematic review. Pediatr. Neurol. 173, 132\u2013141 (2025).","journal-title":"Pediatr. Neurol."},{"key":"735_CR226","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1128\/JVI.72.2.965-974.1998","volume":"72","author":"JF Moffat","year":"1998","unstructured":"Moffat, J. F. et al. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J. Virol. 72, 965\u2013974 (1998).","journal-title":"J. Virol."},{"key":"735_CR227","doi-asserted-by":"publisher","first-page":"11969","DOI":"10.1073\/pnas.95.20.11969","volume":"95","author":"JF Moffat","year":"1998","unstructured":"Moffat, J. F. et al. The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc. Natl Acad. Sci. USA 95, 11969\u201311974 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"735_CR228","doi-asserted-by":"publisher","first-page":"6490","DOI":"10.1073\/pnas.0501045102","volume":"102","author":"L Zerboni","year":"2005","unstructured":"Zerboni, L., Ku, C. C., Jones, C. D., Zehnder, J. L. & Arvin, A. M. Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc. Natl Acad. Sci. USA 102, 6490\u20136495 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Reviews Disease Primers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00735-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00735-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00735-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:02:06Z","timestamp":1788418926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00735-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":228,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["735"],"URL":"https:\/\/doi.org\/10.1038\/s41572-026-00735-5","relation":{},"ISSN":["2056-676X"],"issn-type":[{"value":"2056-676X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"5 August 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.A.N. has an advisory role and participates in studies supported by\u00a0GSK (makers of Shingrix). R.M. participates in studies supported by GSK. C.W.-G. declares consulting fees from GSK, received by the London School of Hygiene and Tropical Medicine. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"58"}}